Dan Lepanto
Senior Managing Director, Healthcare Mergers & AcquisitionsDan Lepanto is a Senior Managing Director in Investment Banking at Leerink Partners focused on Biopharma Mergers & Acquisitions.
Prior to joining the Firm in 2008, Mr. Lepanto spent 10 years at Cowen and Company where he executed a range of biopharma M&A transactions. He began his career in the Mergers & Acquisitions group at Wasserstein Perella. Mr Lepanto has advised on a number of biopharma and healthcare transactions over the span of his career including the sale of Dicerna to Novo Nordisk, the sale of Dermira to Eli Lilly, the sale of NPS to Shire, the sale of Cynosure to Hologic, the sale of TKT to Shire, the sale of GelTex to Genzyme, the merger of Total Renal Care with Renal Treatment Centers and the acquisition of Vivra by Gambro.
Mr. Lepanto earned his B.S. in Finance with High Honors from Pennsylvania State University.
